Bristol-Myers Squibb to pay Mo. more than $11M to settle Medicaid fraud case

Tuesday, July 15, 2008 | 2:07 p.m. CDT

JEFFERSON CITY — Bristol-Myers Squibb has agreed to pay Missouri more than $11 million to resolve claims of Medicaid fraud.

The payment is part of a national settlement in which the drug-maker has agreed to pay hundreds of millions of dollars to 44 states and the federal government. Missouri’s portion of the settlement was announced Tuesday.

The New York-based pharmaceutical giant and former generic subsidiary Apothecon are accused of bilking states by overstating prices for prescription drugs and bribing pharmacies and doctors to use the companies’ medicines.

The drugmakers are also accused of promoting an off-label use for an anti-psychotic drug and engaging in a scheme to lower the rebate payments that the pharmaceutical companies had to pay to the states.

»Contact an editor with corrections or additional information

Comments

Leave a comment

Speak up and join the conversation! You can comment below. (Click here to register.) Please be civil and refrain from profanities and name-calling; in other words; don't say anything you wouldn't outherwise say in public. If you see something objectionable, please tell us which comment and why it should be removed. When you post, please use your actual name. Read the full comment policy here.


(Forgotten your password?)


advertisements